TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Clarient to Present at Upcoming Investment Conferences in New York City (PR Newswire) Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make investor presentations at two upcoming investor conferences in New York City. us.rd.yahoo.com |
Cooking with Heart for the Heart - Video New Cookbook Offers 151 Fresh, Fast, and Flavorful Recipes Made with Canola Oil. feedproxy.google.com |
Swine Flu Continues to Hit Young The H1N1 flu virus continues to disproportionately affect young people, with government figures on hospitalizations from August to October showing 53% were in people age 24 and younger. online.barrons.com |
BioMed News Bytes: GeoVax, Cerus, Discovery Labs, NeurogesX Mike Havrilla submits:On 11/17/09, GeoVax (GOVX.OB) announced that the FDA has granted its request for a pre-IND meeting to discuss the proposed Investigational New Drug (IND) application for the Company’s therapeutic vaccine as a treatment for individuals already infected with HIV. The meeting will only take place if the Company is not satisfied or requires some clarification to the FDA's answers to the questions submitted in the pre-IND package. Following the FDA response to the Pre-IND meeting questions, GeoVax will prepare and submit to the FDA an IND application for the therapeutic trial. A new IND with the FDA is required since this will be the first time the GeoVax vaccine will be used for a therapeutic application. The IND process is expected to take a number of months to complete and based on the Company's current progress, commencement of the trial is targeted for early 2010.Complete Story » seekingalpha.com |
Coffee's Health Perks Coffee may have some health benefits, but it can brew trouble in people with certain conditions. online.wsj.com |